Literature DB >> 20168205

HIV is associated with thrombophilia and high D-dimer in children and adolescents.

Giuseppe Pontrelli1, Alessandra M Martino, Hyppolite K Tchidjou, Rita Citton, Nadia Mora, Lucilla Ravà, Alberto E Tozzi, Paolo Palma, Maurizio Muraca, Elisabetta Franco, Paolo Rossi, Stefania Bernardi.   

Abstract

BACKGROUND AND
OBJECTIVE: Atherosclerosis and other cardiovascular diseases associated with thrombosis appear more relevant and anticipated in HIV-infected patients after combination antiretroviral therapy (cART) has reduced AIDS-related diseases and has improved survival. The association between viral replication and coagulation abnormalities in a cohort of HIV-infected children and adolescents was investigated here.
METHODS: Protein S, protein C anticoagulant and antithrombin activity, together with fibrinogen, D-dimer, high-sensitive C-reactive protein and homocysteine were assayed in a cross-sectional study among a cohort of HIV-infected children and adolescents. Results in patients with high viral load (HVL, HIV-RNA > 1000 copies/ml) were compared with those in patients with a lower replication (LVL), adjusting for other demographic, clinical and therapeutic covariates.
RESULTS: Eighty-eight patients (mean age 13.5 years, CD4 30%, 72% with LVL) were enrolled. A prevalence of protein S and protein C deficiency of 51 and 8% was, respectively, found. HVL group compared to LVL showed a significant reduction of protein S, protein C and antithrombin activities, and an increase of D-dimer levels. The independent association of HVL with decreased protein S activity (-11.2%, P = 0.04) and increased D-dimer levels (+0.13 microg/ml, P = 0.004) was confirmed in the multivariate model.
CONCLUSIONS: HIV-infected children and adolescents present high prevalence of thrombophilic abnormalities. The multivariate model confirmed that high viral replication is independently associated with decrease of protein S and increase of D-dimer, suggesting the advantage of suppressive therapy on coagulation homeostasis and the opportunity of an active control of cardiovascular risk factors starting at a younger age.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20168205     DOI: 10.1097/QAD.0b013e328337b9a0

Source DB:  PubMed          Journal:  AIDS        ISSN: 0269-9370            Impact factor:   4.177


  9 in total

Review 1.  Biomarkers of immune dysfunction in HIV.

Authors:  Daniel E Nixon; Alan L Landay
Journal:  Curr Opin HIV AIDS       Date:  2010-11       Impact factor: 4.283

2.  A clinical cardiology perspective of thrombophilias.

Authors:  Richard C Becker
Journal:  J Thromb Thrombolysis       Date:  2010-10       Impact factor: 2.300

3.  Analysis of the Coagulation Profile in Children with HIV Infection-Effect of Disease and Anti Retroviral Therapy.

Authors:  Priya Thomas; Sunita Sharma; Jagdish Chandra; Anita Nangia; Shivali Sehgal
Journal:  Indian J Hematol Blood Transfus       Date:  2021-05-05       Impact factor: 0.900

Review 4.  Markers of coagulation and inflammation often remain elevated in ART-treated HIV-infected patients.

Authors:  Nicholas T Funderburg
Journal:  Curr Opin HIV AIDS       Date:  2014-01       Impact factor: 4.283

5.  Systemic and intrathecal immune activation in association with cerebral and cognitive outcomes in paediatric HIV.

Authors:  C Blokhuis; C F W Peeters; S Cohen; H J Scherpbier; T W Kuijpers; P Reiss; N A Kootstra; C E Teunissen; D Pajkrt
Journal:  Sci Rep       Date:  2019-05-29       Impact factor: 4.379

6.  E-Selectin and markers of HIV disease severity, inflammation and coagulation in HIV-infected treatment-naïve individuals.

Authors:  Madelein Hoffman; Hayley Ipp; Dineo V Phatlhane; Rajiv T Erasmus; Annalise E Zemlin
Journal:  Afr Health Sci       Date:  2018-12       Impact factor: 0.927

7.  Derangement of protein S and C4b-binding protein levels as acquired thrombophilia in HIV-infected adult Nigerians.

Authors:  Fatai O Bello; Alani S Akanmu; Titilope A Adeyemo; Bukunmi M Idowu; Prosper Okonkwo; Phyllis J Kanki
Journal:  South Afr J HIV Med       Date:  2021-08-23       Impact factor: 2.744

8.  Hemostasis in elderly patients with human immunodeficiency virus (HIV) infection-Cross-sectional study.

Authors:  Marilza Campos de Magalhães; Juan Camilo Sánchez-Arcila; Ana Carolina de Brito Lyra; Luiz Felipe Boufleur Long; Isabelle Vasconcellos de Souza; Fernando Raphael de Almeida Ferry; Adilson José de Almeida; Soniza Vieira Alves-Leon
Journal:  PLoS One       Date:  2020-02-12       Impact factor: 3.240

9.  Hepatic, Renal, Hematologic, and Inflammatory Markers in HIV-Infected Children on Long-term Suppressive Antiretroviral Therapy.

Authors:  Ann J Melvin; Meredith Warshaw; Alexandra Compagnucci; Yacine Saidi; Linda Harrison; Anna Turkova; Gareth Tudor-Williams
Journal:  J Pediatric Infect Dis Soc       Date:  2017-09-01       Impact factor: 3.164

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.